Official panel on COVID-19 recommends use of plasma therapy to treat patients in J&K
10-member panel headed by Dr Khuroo submits recommendations to government
Srinagar: Fifteen days after a 10-member high-level advisory panel was constituted to review the protocol, guidelines and other related issues about the treatment of Covid-19 patients and their implementation, the committee has submitted their views based on research to the government.
Head of the committee Dr. Mohammed Sultan Khuroo was quoted by news agency KNO as saying that several meetings were held between all the members of the committee where every issue related to Covid-19 was discussed and the same was put forward to the government.
“We are hopeful that in the next two days the government will approve our recommendations. The committee held discussions based on literature available and have put forward the same to the government,” he said.
He said that in the report they have mentioned which drug is required at which time based on research and have also given a detailed report about isolation, discharge, home quarantine and administrative quarantine with regard to Covid-19 pandemic.
He said that they have also communicated to the government to start plasma therapy on priority basis and that it be carried out in a meticulous manner.
“If drugs are given at an appropriate time, plasma therapy is being started and other guidelines are followed in letter and spirit, we can save many lives,” he said.
On being asked if there any hospital capable here where plasma therapy can be done, he said they have facilities available at SKIMS Soura and GMC Jammu where this process can be started, and in future it can be started in other hospitals as well.
“Plasma method has a simple premise. The blood of people who have recovered from an infection contains antibodies. Antibodies are molecules that have learned to recognize and fight the pathogens, such as viruses, that have caused disease,” he said.
He said that doctors can separate plasma, one of the blood components that contain such antibodies and administer it to people whose bodies are currently fighting an infectious disease. “This can help their immune systems reject the pathogen more efficiently.”
He further added that the public must fight this deadly virus seriously and should not believe in a few medicos who are saying that a vaccine will be available in three or four months. They must know that it will take time because even the experimental process takes years.
He said that people must follow guidelines and should not go out unnecessarily and whenever they have to go out, wear a mask and maintain social distance.
“Gathering in a closed atmosphere can prove more dangerous in terms of the spread of virus than open gatherings,” he said.
He said that they are hopeful that the government will take their recommendations seriously and all important things mentioned in the report will be approved.
Pertinently, on June 15 the Jammu and Kashmir government had constituted a 10-member high level advisory panel headed by Dr Kharoo to review the protocol, guidelines and other related issues about the treatment of COVID-19 patients and their implementation. (With KNO inputs)